{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:00:08Z","timestamp":1775545208227,"version":"3.50.1"},"reference-count":12,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMJ"],"DOI":"10.4274\/mmj.galenos.2022.55453","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T02:54:07Z","timestamp":1645066447000},"source":"Crossref","is-referenced-by-count":1,"title":["Invasive Heart Rate Control as a Salvage Therapy in Amiodarone-induced Thyroid Storm"],"prefix":"10.4274","author":[{"given":"Emin Evren","family":"OZCAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"DOGDUS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Resit Yigit","family":"YILANCIOGLU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suleyman Cem","family":"ADIYAMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguzhan Ekrem","family":"TURAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","unstructured":"1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-962.","journal-title":"Eur Heart J"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1001\/archinte.160.12.1741","article-title":"Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology","volume":"160","author":"Goldschlager","year":"2000","unstructured":"2. Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med. 2000;160:1741-8.","journal-title":"Arch Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","unstructured":"3. Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984;101:28-34.","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/pds.735","article-title":"Amiodarone-induced thyroid dysfunction associated with cumulative dose","volume":"11","author":"Bouvy","year":"2002","unstructured":"4. Bouvy ML, Heerdink ER, Hoes AW, Leufkens HG. Amiodarone-induced thyroid dysfunction associated with cumulative dose. Pharmacoepidemiol Drug Saf. 2002;11:601-6.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Marrakchi S, Kanoun F, Idriss S, Kammoun I, Kachboura S. Arrhythmia and thyroid dysfunction. Herz. 2015;40(Suppl 2):101-9.","DOI":"10.1007\/s00059-014-4123-0"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3949\/ccjm.70.7.624","article-title":"Amiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategies","volume":"70","author":"Cardenas","year":"2003","unstructured":"6. Cardenas GA, Cabral JM, Leslie CA. Amiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategies. Cleve Clin J Med. 2003;70:628-31.","journal-title":"Cleve Clin J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.36660\/abc.20190757","article-title":"Amiodarone-Induced Thyrotoxicosis - Literature Review & Clinical Update","volume":"117","author":"Souza","year":"2021","unstructured":"7. Souza LVF, Campagnolo MT, Martins LCB, Scanavacca MI. Amiodarone-Induced Thyrotoxicosis - Literature Review & Clinical Update. Arq Bras Cardiol. 2021;117:1038-44.","journal-title":"Arq Bras Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/hrt.79.2.121","article-title":"Amiodarone and the thyroid: A practical guide to the management of thyroid dysfunction induced by amiodarone therapy","volume":"79","author":"Newman","year":"1998","unstructured":"8. Newman CM, Price A, Davies DW, Gray TA, Weetman AP. Amiodarone and the thyroid: A practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart. 1998;79:121-7.","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) guidelines for the management of amiodarone - associated thyroid dysfunction","volume":"7","author":"Bartalena","year":"2018","unstructured":"9. Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone - associated thyroid dysfunction. Eur Thyroid J. 2018;7:55-66.","journal-title":"Eur Thyroid J"},{"key":"ref9","unstructured":"10. Garc\u00eda Gil D, Escobar Jim\u00e9nez L, Pi\u00f1ero G\u00e1lvez C, Gir\u00f3n Gonz\u00e1lez JA. Ablation of the hyperconducting atrioventricular node in a patient with thyrotoxicosis induced by amiodarone. Med Clin (Barc). 1995;105:238."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/eupc.1998.0004","article-title":"Ablation of the atrioventricular junction: technique, acute and long-term results in 115 consecutive patients","volume":"1","author":"HJ","year":"1999","unstructured":"11. Marshall HJ, Griffith MJ. Ablation of the atrioventricular junction: technique, acute and long-term results in 115 consecutive patients. Europace. 1999;1:26-9.","journal-title":"Europace"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","article-title":"AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial","volume":"42","author":"Brignole","year":"2021","unstructured":"12. Brignole M, Pentimalli F, Palmisano P, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021;42:4731-9.","journal-title":"Eur Heart J"}],"container-title":["Medeniyet Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:03:37Z","timestamp":1775541817000},"score":1,"resource":{"primary":{"URL":"https:\/\/medeniyetmedicaljournal.org\/articles\/doi\/MMJ.galenos.2022.55453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":12,"URL":"https:\/\/doi.org\/10.4274\/mmj.galenos.2022.55453","relation":{},"ISSN":["2149-2042"],"issn-type":[{"value":"2149-2042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}